Replies to post #388149 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

There are only $6M in regulatory milestones on the B-UP deal. The other $18M is in sales milestones.

Phase 3 start = $1M
Phase 3 success = $1M
Filing NDA = $1M
Receiving NDA = $3M

$100M sales= $3M payment
$200M sales = $6M payment
$300M sales = $9M payment

My hope is we would have a successful oral B-UC trial before then. In which case I think AS would stop development of the inferior UP delivery system.

Advancement of B-UP just secures the payroll for a few more years. Think of it as Leo's pension plan should all the other drugs fall through.

It wont do shareholders much good.